{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:29:44Z","timestamp":1776187784526,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T00:00:00Z","timestamp":1367971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s11033-013-2551-1","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T05:05:30Z","timestamp":1367903130000},"page":"4591-4596","source":"Crossref","is-referenced-by-count":22,"title":["CXCL12 and TP53 genetic polymorphisms as markers of susceptibility in a Brazilian children population with acute lymphoblastic leukemia (ALL)"],"prefix":"10.1007","volume":"40","author":[{"given":"Aparecida","family":"de Lourdes Perim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta Losi","family":"Guembarovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Massayo Maeda","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandra Fiori","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina Batista","family":"Ariza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marla Karine","family":"Amarante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Helena Pelegrinelli","family":"Fungaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen Braj\u00e3o","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Angelica Ehara","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,8]]},"reference":[{"key":"2551_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.transci.2011.01.009","volume":"44","author":"C Graux","year":"2011","unstructured":"Graux C (2011) Biology of acute lymphoblastic leukemia (ALL): clinical and therapeutic relevance. Transfus Apher Sci 44:183\u2013189","journal-title":"Transfus Apher Sci"},{"key":"2551_CR2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1289\/ehp.9023","volume":"115","author":"M Belson","year":"2007","unstructured":"Belson M, Kingsley B, Holmes A (2007) Risk factors for acute leukemia in children: a review. Environ Health Perspect 115:138\u2013145","journal-title":"Environ Health Perspect"},{"key":"2551_CR3","unstructured":"INCA (2011) Estimate 2012: cancer incidence in Brazil, Rio de Janeiro"},{"key":"2551_CR4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1189\/jlb.0310182","volume":"89","author":"P Mishra","year":"2011","unstructured":"Mishra P, Banerjee D, Ben-Baruch A (2011) Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol 89:31\u201339","journal-title":"J Leukoc Biol"},{"key":"2551_CR5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50\u201356","journal-title":"Nature"},{"key":"2551_CR6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bcmd.2004.04.008","volume":"33","author":"GG Oliveira Cavassin de","year":"2004","unstructured":"de Oliveira Cavassin GG, De Lucca FL, Delgado Andre N et al (2004) Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil. Blood Cells Mol Dis 33:90\u201393","journal-title":"Blood Cells Mol Dis"},{"key":"2551_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jcla.20142","volume":"21","author":"CE Oliveira de","year":"2007","unstructured":"de Oliveira CE, Cavassin GG, Perim Ade L et al (2007) Stromal cell-derived factor-1 chemokine gene variant in blood donors and chronic myelogenous leukemia patients. J Clin Lab Anal 21:49\u201354","journal-title":"J Clin Lab Anal"},{"key":"2551_CR8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jcla.20346","volume":"23","author":"KB Oliveira de","year":"2009","unstructured":"de Oliveira KB, Oda JM, Voltarelli JC et al (2009) CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin\u2019s lymphoma, and non-Hodgkin\u2019s lymphoma. J Clin Lab Anal 23:387\u2013393","journal-title":"J Clin Lab Anal"},{"key":"2551_CR9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cyto.2011.04.017","volume":"55","author":"KB Oliveira de","year":"2011","unstructured":"de Oliveira KB, Guembarovski RL, Oda JM et al (2011) CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients. Cytokine 55:260\u2013265","journal-title":"Cytokine"},{"key":"2551_CR10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","volume":"2","author":"KH Vousden","year":"2002","unstructured":"Vousden KH, Lu X (2002) Live or let die: the cell\u2019s response to p53. Nat Rev Cancer 2:594\u2013604","journal-title":"Nat Rev Cancer"},{"key":"2551_CR11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/MCB.7.2.961","volume":"7","author":"GJ Matlashewski","year":"1987","unstructured":"Matlashewski GJ, Tuck S, Pim D et al (1987) Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7:961\u2013963","journal-title":"Mol Cell Biol"},{"key":"2551_CR12","first-page":"429","volume":"23","author":"MN Aoki","year":"2009","unstructured":"Aoki MN, da Silva do Amaral Herrera AC, Amarante MK et al (2009) CCR5 and p53 codon 72 gene polymorphisms: implications in breast cancer development. Int J Mol Med 23:429\u2013435","journal-title":"Int J Mol Med"},{"key":"2551_CR13","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1158\/0008-5472.CAN-06-2323","volume":"66","author":"N Moskovits","year":"2006","unstructured":"Moskovits N, Kalinkovich A, Bar J, Lapidot T, Oren M (2006) p53 Attenuates cancer cell migration and invasion through repression of SDF-1\/CXCL12 expression in stromal fibroblasts. Cancer Res 66:10671\u201310676","journal-title":"Cancer Res"},{"key":"2551_CR14","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"CH Pui","year":"2008","unstructured":"Pui CH, Robison LL, Look AT (2008) Acute lymphoblastic leukaemia. Lancet 371:1030\u20131043","journal-title":"Lancet"},{"key":"2551_CR15","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","volume":"104","author":"CH Pui","year":"2004","unstructured":"Pui CH, Sandlund JT, Pei D et al (2004) Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children\u2019s Research Hospital. Blood 104:2690\u20132696","journal-title":"Blood"},{"key":"2551_CR16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrc2840","volume":"10","author":"O Fletcher","year":"2010","unstructured":"Fletcher O, Houlston RS (2010) Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 10:353\u2013361","journal-title":"Nat Rev Cancer"},{"key":"2551_CR17","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/leu.2009.175","volume":"23","author":"F Ayala","year":"2009","unstructured":"Ayala F, Dewar R, Kieran M, Kalluri R (2009) Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 23:2233\u20132241","journal-title":"Leukemia"},{"key":"2551_CR18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8:275\u2013283","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2551_CR19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s12032-010-9505-4","volume":"28","author":"S Alawadi","year":"2011","unstructured":"Alawadi S, Ghabreau L, Alsaleh M et al (2011) P53 gene polymorphisms and breast cancer risk in Arab women. Med Oncol 28:709\u2013715","journal-title":"Med Oncol"},{"key":"2551_CR20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.mrrev.2005.01.002","volume":"589","author":"CV Moura Gallo de","year":"2005","unstructured":"de Moura Gallo CV, Azevedo e Silva Mendon\u00e7a G, de Moraes E, Olivier M, Hainaut P (2005) TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives. Mutation Res 589:192\u2013207","journal-title":"Mutation Res"},{"key":"2551_CR21","doi-asserted-by":"crossref","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","volume":"2","author":"M Olivier","year":"2010","unstructured":"Olivier M, Hollstein M, Hainaut P (2010) TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2:a001008","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2551_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11060-012-0950-0","volume":"110","author":"RM Carvalho","year":"2012","unstructured":"Carvalho RM, Pinto GR, Yoshioka FK et al (2012) Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients. J Neurooncol 110:49\u201357","journal-title":"J Neurooncol"},{"key":"2551_CR23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12038-012-9183-9","volume":"37","author":"KA Costa","year":"2012","unstructured":"Costa KA, Guillo LA (2012) TP53 codon 72 polymorphism in pigmentary phenotypes. J Biosci 37:33\u201339","journal-title":"J Biosci"},{"key":"2551_CR24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s12038-011-9147-5","volume":"36","author":"HS Thurow","year":"2011","unstructured":"Thurow HS, Haack R, Hartwig FP et al (2011) TP53 gene polymorphism: importance to cancer, ethnicity and birth weight in a Brazilian cohort. J Biosci 36:823\u2013831","journal-title":"J Biosci"},{"key":"2551_CR25","first-page":"1926","volume":"58","author":"Y Liu","year":"2011","unstructured":"Liu Y, Qin H, Zhang Y et al (2011) P53 codon 72 polymorphism and colorectal cancer: a meta-analysis of epidemiological studies. Hepatogastroenterology 58:1926\u20131929","journal-title":"Hepatogastroenterology"},{"key":"2551_CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cancergencyto.2009.05.009","volume":"195","author":"TN Do","year":"2009","unstructured":"Do TN, Ucisik-Akkaya E, Davis CF, Morrison BA, Dorak MT (2009) TP53 R72P and MDM2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility. Cancer Genet Cytogenet 195:31\u201336","journal-title":"Cancer Genet Cytogenet"},{"key":"2551_CR27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1590\/S1676-24442004000200008","volume":"40","author":"MG Farias","year":"2004","unstructured":"Farias MG, Castro SMd (2004) Diagn\u00f3stico laboratorial das leucemias linf\u00f3ides agudas. J Bras Patol Med Lab 40:91\u201398","journal-title":"J Bras Patol Med Lab"},{"key":"2551_CR28","doi-asserted-by":"crossref","unstructured":"Felix CA, Lange BJ, Chessells JM (2000) Pediatric acute lymphoblastic leukemia: challenges and controversies in 2000. Hematol Am Soc Hematol Educ Program 285\u2013302","DOI":"10.1182\/asheducation-2000.1.285"},{"key":"2551_CR29","first-page":"322","volume":"36","author":"CH Pui","year":"1995","unstructured":"Pui CH (1995) Childhood leukemias\u2014current status and future perspective. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 36:322\u2013327","journal-title":"Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2551-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-013-2551-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2551-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T09:15:21Z","timestamp":1563009321000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-013-2551-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,8]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2551"],"URL":"https:\/\/doi.org\/10.1007\/s11033-013-2551-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,8]]}}}